Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Black Diamond Therapeutics Inc (NASDAQ: BDTX) was $2.49 for the day, up 2.47% from the previous closing price of $2.43. In other words, the price has increased by $2.47 from its previous closing price. On the day, 0.83 million shares were traded. BDTX stock price reached its highest trading level at $2.51 during the session, while it also had its lowest trading level at $2.41.
Ratios:
Our analysis of BDTX’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.05 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.64. For the most recent quarter (mrq), Quick Ratio is recorded 8.94 and its Current Ratio is at 8.94. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.13.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 19 ’25 when BIOTECH GROWTH N V sold 5,784,292 shares for $2.07 per share. The transaction valued at 11,997,749 led to the insider holds 2,733,547 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BDTX now has a Market Capitalization of 141867536 and an Enterprise Value of 26034534. As of this moment, Black’s Price-to-Earnings (P/E) ratio for their current fiscal year is 6.86. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.03 while its Price-to-Book (P/B) ratio in mrq is 1.12. Its current Enterprise Value per Revenue stands at 0.372 whereas that against EBITDA is 1.719.
Stock Price History:
The Beta on a monthly basis for BDTX is 3.40, which has changed by 0.1690141 over the last 52 weeks, in comparison to a change of 0.14778805 over the same period for the S&P500. Over the past 52 weeks, BDTX has reached a high of $4.94, while it has fallen to a 52-week low of $1.20. The 50-Day Moving Average of the stock is -26.59%, while the 200-Day Moving Average is calculated to be -9.62%.
Shares Statistics:
BDTX traded an average of 1.20M shares per day over the past three months and 935140 shares per day over the past ten days. A total of 56.94M shares are outstanding, with a floating share count of 44.75M. Insiders hold about 21.46% of the company’s shares, while institutions hold 58.79% stake in the company. Shares short for BDTX as of 1765756800 were 6298943 with a Short Ratio of 5.26, compared to 1763078400 on 6356283. Therefore, it implies a Short% of Shares Outstanding of 6298943 and a Short% of Float of 15.870000000000001.
Earnings Estimates
The stock of Black Diamond Therapeutics Inc (BDTX) is currently drawing attention from 6.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is $0.06, with high estimates of $1.03 and low estimates of -$0.22.
Analysts are recommending an EPS of between $0.47 and $0.34 for the fiscal current year, implying an average EPS of $0.42. EPS for the following year is -$0.6, with 6.0 analysts recommending between -$0.19 and -$0.83.
